Msn - Profile
✉ Email this page to a colleague
Drugs and US Patents for Msn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209878-002 | Nov 20, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Msn | DEFERASIROX | deferasirox | GRANULE;ORAL | 214650-001 | Mar 17, 2021 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Msn | CAPECITABINE | capecitabine | TABLET;ORAL | 209365-001 | Jul 2, 2018 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Msn Labs Pvt Ltd | LACOSAMIDE | lacosamide | TABLET;ORAL | 204921-002 | Mar 17, 2022 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Msn | PACLITAXEL | paclitaxel | INJECTABLE;INJECTION | 213434-001 | Aug 24, 2020 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |